Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Nature 607, 33-34 (2022)
Diamantopoulou, Z. et al. Nature 607, 156–162 (2022).
Taftaf, R. et al. Nature Commun. 12, 4867 (2021).
Rupp, B., Ball, H., Wuchu, F., Nagrath, D. & Nagrath, S. Trends Pharmacol. Sci. 43, 378–391 (2022).
Poudineh, M., Sargent, E. H., Pantel, K. & Kelley, S. O. Nature Biomed. Eng. 2, 72–84 (2018).
Szczerba, B. M. et al. Nature 566, 553–557 (2019).
Bishehsari, F., Voigt, R. M. & Keshavarzian, A. Nature Rev. Endocrinol. 16, 731–739 (2020).
Masri, S. & Sassone-Corsi, P. Nature Med. 24, 1795–1803 (2018).
Giuliano, M. et al. Cancer Res. 78, 845–852 (2018).
Keller, L. & Pantel, K. Nature Rev. Cancer 19, 553–567 (2019).
Kim, T. H. et al. Nature Commun. 10, 1478 (2019).
S.N. is one of the named inventors on a patent for Microfluidic Labyrinth Technology granted to the University of Michigan. This IP is licensed to the company Labyrinth Biotech. S.N. is the co-founder with equity interests and a scientific advisory board member for Labyrinth Biotech.